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The ability of spleen cells from Chlamydia psittaci-infected mice to lyse C.
psittaci-infected and uninfected target cell monolayers was studied. The cytotox-
icity assay used was a terminal label method in which the number of adherent
target cells surviving the interaction with effector cells was determined by
measuring the uptake of [3H]uridine by such cells. It was observed that in the first
few days postinfection (3 to 5), spleens contained cells that lysed infected and
uninfected targets with equal efficiency. Subsequently, infected targets were
killed primarily. The activity of effector spleen cells for infected targets continued,
although at a reduced level, beyond 21 days postinfection. Intact effector cells
were required since a disruption by sonication resulted in a loss of cytotoxicity.
The enhanced killing observed with infected targets was also observed when
target cells were sensitized with heat- or UV-inactivated C. psittaci. This study
suggests that the induction of cytotoxic cells after C. psittaci infection may
contribute to the ability of the host to control multiplication of the microorganism.
Chlamydiae are obligate intracellular bacteria
that infect and subsequently multiply in macro-
phages and epithelial cells. The multiplication
process appears to be accompanied by the re-
lease of chlamydial antigen in the extracellular
supernatant and possibly on the surface of in-
fected cells (20, 21). Diseases caused by the
genus Chlamydia, such as trachoma, sexually
transmitted diseases, and psittacosis, are char-
acterized by a chronic or latent and relapsing
course (25). The host is capable of generating
both humoral and cellular immune responses,
but the relative importance of these responses in
the control of infection, as well as in the patho-
genesis of infection, is not entirely clear. Studies
with vaccines and passive transfer of antibody
(3, 8, 16, 28) suggest that antibody alone is not
sufficient to protect the host from infection or
for the resolution of an established infection.
Chlamydiae can induce interferon in the host
after injection, interferon can inhibit inclusion
formation in vitro, and there is some suggestion
of an association between induction of interfer-
on in vivo and control of infection (11, 13, 14).
Recent interest has focused on the role of cellu-
lar immunity. Cellular immunity has been dem-
onstrated in vivo by skin testing with chlamydial
antigen and in vitro by macrophage migration
inhibition and lymphocyte transformation (9, 22,
23, 27). Page (17) found that immunity in chick-
ens correlates more closely with the ability of
lymphocytes to be transformed by chlamydial
antigen than with the antibody levels. Protection
can be abolished if the animals are thymecto-
mized before immunization, whereas bursec-
tomy has little effect. The mechanisms whereby
cells from the host may control chlamydial mul-
tiplication have not yet been defined. Activated
macrophages, as described by Mackaness (12),
might play a role in the control of chlamydial
multiplication. Some types of chlamydiae, how-
ever, grow in vivo in epithelial cells, as well as
macrophages, and have specialized receptors to
facilitate their uptake into such cells (5). There-
fore, it seems unlikely that this mechanism of
cell-mediated immunity would be as effective
against Chlamydia as it is against intracellular
organisms that reside primarily in macrophages.
A common method of cellular control in viral
infections is the killing of infected cells by both
specific and nonspecific host-generated cytotox-
ic cells. Chlamydial infection of cells is similar to
viral infection in many ways, and in this study
we examined whether spleens from infected
mice contain cells that are capable of lysing
Chlamydia-infected target cells in vitro. Evi-
dence is presented which indicates that cytotox-
ic cells capable of lysing infected targets are
present in the spleens of infected animals.
MATERIALS AND METHODS
Growth and purification of Chlamydia. The Cal 10
meningopneumontis strain of C. psittaci was grown in
929 L cell suspension cultures (26). L cells were tested
and found to be free from mycoplasma contamination
(courtesy of Wallace Clyde, Department of Pediatrics,
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Chapel Hill, N.C.). Cell-free supernatants from L cell
cultures were harvested 48 h postinfection and sub-
jected to differential centrifugation followed by centri-
fugation through 30%o sucrose cushions and discontin-
uous (38, 44, 59% [vol/vol]) Renografin gradients (31).
Infectivity was assayed by the inclusion-forming-unit
technique (31). Purified chlamydiae were treated by
UV light by the procedure of Byrne and Moulder (5).
Heat treatment consisted of suspending the organisms
in phosphate-buffered saline (PBS) and incubating in a
56°C water bath for 30 min. Infectivity after both
treatments was assayed by the inclusion-forming-unit
technique and was less than 1%.
Animals and experimental infection. Female Fl
(C57BL6 x C3H) mice (Cumberland View Farms,
Tenn.) between 8 and 12 weeks of age were used in
most studies. Untreated mice appeared to be free of
prior chlamydial infection, as judged by the lack of
neutralizing antibody and the inability to grow the
organism out of the livers and spleens of such mice
even after hydrocortisone treatment. Experimental
infection consisted of the intraperitoneal injection of 8
x 107 infectious organisms per mouse. This resulted in
the establishment of a systemic infection, and the
chlamydiae could be grown out of the liver and spleen
during the first few weeks. This was followed by the
establishment of a latent form of the infection. At 1
month postinfection, small numbers of chlamydiae
could be grown out of the spleen when spleen cell
suspensions were cocultivated with L cells.
Such mice were resistant to subsequent challenge
with a lethal dose of inoculum, indicating that a
successful host cell response had been mounted. In
early studies control mice were injected intraperitone-
ally with L cell material processed in the same manner
as the chlamydiae or with PBS. No difference was
detected in spleen cell response with the two methods,
so in later studies control mice were injected with
PBS. After injection, the animals were maintained in
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FIG. 1. Correlation between [3H]uridine uptake
and peritoneal macrophage number.
Effector cells. Spleen cells were used as the source of
effector cells. Spleens were removed from infected or
control mice, and cells were teased from the spleens.
Erythrocytes were lysed by treatment with 0.83% (wt/
vol) NH4Cl or by hypotonic shock. No difference in
activity by spleen cells was observed after the two
different methods. Cells were washed three times and
suspended in RPMI 1640 supplemented with 10%o heat-
inactivated fetal bovine serum (KC Biological, Len-
exa, Kans.), 0.02% streptomycin, 0.1% kanamycin,
and 2 mM glutamine. Viable cells were counted by
trypan blue exclusion and adjusted to the appropriate
concentration depending on the particular effector/
target cell ratio. In early studies ratios of 100:1 to 6:1
were used. A 50:1 ratio was found to give good
cytotoxicity and was used in subsequent studies.
Target cells. Peritoneal macrophages or L-929
monolayer cells were used as targets because chla-
mydial infection in these cells has been well character-
ized. Peritoneal macrophages were obtained from
mice that had been injected intraperitoneally with 3.0
ml of thioglycolate 5 days before harvest. Cells were
harvested by the method of Cohn and Benson (6) and
washed two times, and viable cells were counted by
the trypan blue exclusion technique, and the concen-
tration was adjusted to 7 x 10' macrophages per ml in
RPMI 1640. Cells were dispensed in 0.1-ml samples
into the wells of 96-well flat-bottomed microtiter plates
(Falcon Plastics, Oxnard, Calif.). After incubation at
37°C in an atmosphere of 5% CO2 for 2 h, cells were
washed three times to remove nonadherent cells, and
fresh medium was added. After the cells had incubated
for 24 h, the medium was removed, and infectious C.
psittaci were added at a 5:1 ratio in 0.1 ml of medium
per well. Microtiter plates were centrifuged for 30 min
at 1,500 rpm in an International centrifuge (model Pr-2;
International Equipment Co., Boston, Mass.) followed
by incubation for 5 h at 37°C. The inoculum was then
removed, and effector cells were added. When L cells
were used, the same procedure was followed except
that L cells were added to microtiter plates in 0.1 ml of
7.8 x 104 cells per ml and incubated for 12 h before the
addition of inoculum.
Cytotoxicity assay. Preliminary studies indicated that
a 5'Cr release assay was unsatisfactory because of
high background release with peritoneal macrophage
monolayers. As an alternative, the [3H]uridine uptake
technique of Smith and Nicklin (24) was used. This is a
terminal label assay in which adherent target cells
surviving the interaction with the effector cells are
assessed for their ability to transport [3H]uridine,
which is an energy-dependent process. A major advan-
tage of this technique is that spontaneous release is
negligible because targets are labeled after incubation.
Preliminary studies indicated a direct correlation be-
tween the uptake of label and the number of macro-
phages in culture (Fig. 1). A similar correlation was
observed with L cells. There was a good correlation
between cell counts done visually, when plates were
stained after the assay was completed, and the [3H]uri-
dine uptake by survivors. In the assay, effector cells
were added to target cells at a 50:1 ratio. When using
monolayers as target cells, optimal killing has been
observed between 6 and 72 h (4, 32, 33). In these
studies, virtually no killing was observed after a 4-h
incubation of effector and target cells, whereas 24 h
resulted in a high level of kill. Therefore, effector and
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target cells were incubated together for 24 h at 37°C.
Effector cells were then removed by washing the
monolayer with PBS; a 0.1-ml sample of medium
containing 4 ,uCi of [3H]uridine (20 Ci/mmol; Moravek
Biochemicals, City of Industry, Calif.) was added to
each well, and the cultures were incubated for an
additional 2 h at 37°C. The radioactive medium was
subsequently removed, monolayers were washed
three times with PBS, and 0.1 ml of cold 5% trichloro-
acetic acid was added to each well. Ten minutes later
the trichloroacetic acid from each well was transferred
to a vial, and scintillation fluid was added (Scintiverse;
Fisher Scientific Co., Fairlawn, N.J.) and counted in a
Packard liquid scintillation counter. In some experi-
ments, the residue in the wells was washed with
ethanol and then stained with Giemsa. Cell numbers
could thus be counted visually. Since not all of the
effector cells were washed away before the labeling
period, some wells were run with effector cells alone
(no target monolayer) and processed in the same way.
This gave a value for [3H]uridine uptake due to residu-
al sticking of effector cells and was subtracted from the
uptake observed in wells of monolayers that had been
incubated with effectors. The results of [3H]thymidine
incorporation into target cells were calculated as fol-
lows:
percent target cell destruction =
(1 - cpm uptake sensitized effectors) x 100
(cpm uptake unsensitized effectors)
Lymphocyte transformation. Spleen cell suspensions
were prepared at a concentration of 5 x 106 cells per
ml in RPMI 1640 containing 10-' M 2-mercaptoeth-
anol. A 0.1-ml sample was added to the well of a
microtiter plate along with 0.1 ml of chlamydial anti-
gen and incubated for 5 days. Cells were subsequently
pulsed with [3H]thymidine for 24 h and harvested with
a MASH II automatic harvester. Samples were dried,
placed in Econofluor (New England Nuclear Corp.,
Boston, Mass.), and counted in a Packard liquid
scintillation counter. Chlamydial antigen consisted of
purified elementary body that had been UV inactivat-
ed and stored at -70°C until use. The protein concen-
tration was adjusted to 1.5 Fg/ml, and 0.1 ml was
added to the microtiter wells.
Statistics. In all experiments, numbers represent the
mean of quadruplicate cultures. Standard deviations
were generally less than 10%o. Differences in uptake of
[3H]uridine by targets incubated with effectors from
Chlamydia-infected mice or control mice were ana-
lyzed by Student's t test.
RESULTS
If cytotoxic cells capable of killing Chla-
mydia-infected targets play a role in the control
of infection with Chlamydia, it might be expect-
ed that such cells would be present in the
immune mouse. Mice were immunized with in-
fectious C. psittaci or their spleens were re-
moved and tested for the presence of cytotoxic
effector cells. Of the mice challenged with infec-
tious C. psittaci, 100% of controls (11 mice per
group) died by 6 days postchallenge, whereas
none of the boosted mice died during a 1-month
observation period postchallenge. Spleen cells
from boosted mice killed C. psittaci-infected
targets better than cells from control animals at
effector/target cell ratios of 50:1 and 25:1 (Table
1). There was essentially no killing of uninfected
target cells. There did appear to be a background
level of killing of infected targets by control
spleen cells. When the [3H]uridine uptake of
infected target cell monolayers incubated with
control spleen cells was compared with the
uptake of targets incubated with medium, a 30%
reduction was observed. In parallel with cyto-
toxicity testing, spleen cells from the boosted
mice were tested for their ability to be trans-
formed in the presence of chlamydial antigen.
Cells from boosted animals had a stimulation
index of 13.6, whereas cells from control ani-
mals had a stimulation index of 1.9. This indi-
cates that in the boosted mice a chlamydia-
TABLE 1. Cytotoxicity of mouse spleen cells for uninfected or C. psittaci-infected targetsa
E:T Effector [3H]uridine uptake (103 cpm ± SD)spleen cells M.+C.p.b Cytotoxicityc M4)+medium % Cytotoxicity
50:1 C. psittaci 40.1 ± 3.2 41 114 ± 13 0
Control 68.3 ± 4.9 96.1 ± 2.9
Medium 96.8 ± 2.6 102 ± 7.2
25:1 C. psittaci 49.9 ± 4.7 21 101 ± 8.3 0
Control 63.1 ± 4.9 96.8 ± 9.7
12:1 C. psittaci 53.9 ± 5.0 3 105 ± 9.3 2
Control 55.8 ± 3.5 107 ± 8.2
a Mice were injected with 8 x 107 infectious C. psittaci or PBS and boosted at 3 weeks with the same
concentration, and spleen cells were harvested 1 week later. Abbreviations: E:T, effector/target cell ratio;
M4+C.p., target macrophage monolayer infected with C. psittaci; M4+medium, target macrophage monolayer
uninfected.
b [3H]uridine uptake by target cells = 103 cpm ± standard deviation.
c Percent cytotoxicity - (1 - cpm target with sensitized effector)




FIG. 2. Cytotoxicity of spleen cells from C. psit-
taci-infected mice for infected and uninfected macro-
phage targets.
specific cell-mediated immune response existed.
It was clear that spleen cells from Chlamydia-
infected mice could kill infected target cells in
vitro to a greater degree than could spleen cells
from control mice. The time of appearance of
such cells in the spleen after infection was of
interest. It can be seen from Fig. 2 that killing of
C. psittaci-infected cells increased steadily from
day 1 postinfection, reached a peak between
days 7 and 9, and then leveled out. In contrast to
what was observed with the boosted mice, some
killing of uninfected targets was also observed.
This killing peaked between days 3 and 7 and
disappeared by 2 weeks postinfection.
The ability to lyse Chlamydia-infected target
cells appeared to require an intact effector cell.
When effector spleen cells were lysed by sonifi-
cation before addition to target cell monolayers
(Table 2), cytotoxicity was largely abolished.
This was true for effector spleen cells harvested
early after infection (day 3) when both infected
and uninfected target cells were lysed, as well as
later on (day 14), when only infected target cells
were lysed.
The enhanced cytotoxicity of effector spleen
cells for infected targets raised the question of
what is required for target cell induction. In
addition to infectious C. psittaci, UV- and heat-
inactivated organisms were centrifuged onto
macrophage monolayers (Table 3). Effector cells
from C. psittaci-infected mice killed targets sen-
sitized with inactivated C. psittaci at the same
level as targets sensitized with infectious organ-
isms. Macrophages are known to phagocytize
both UV-inactivated and heat-inactivated organ-
isms. In contrast, whereas UV-inactivated C.
psittaci can induce their own uptake into L cells,
heat-inactivated organisms have largely lost this
ability (5). When treated and infectious organ-
isms were centrifuged onto L cell monolayers
(Table 4), all targets were killed at the same level
as observed with macrophage monolayers. Cen-
trifuge-assisted infection of cells is frequently
used with chlamydiae since attachment and sub-
sequent infection are greatly enhanced. There is
evidence however, that centrifugation may mod-
ulate the cell surface and the susceptibility to
Chlamydia (1, 2). Thus it was possible that the
observed sensitization of target cells was due to
changes of the cell surface induced by centrifu-
gation of chlamydial particles onto the surface
and not due to the chlamydiae specifically.
However, when the microorganisms were added
and allowed to interact by shaking rather than
centrifugation, cytotoxicity was also observed
TABLE 2. Cytotoxicity of target cells requires intact effector cellsa
Days Effector V3H]undine uptake (103 cpm ± SD)
postinfection spleen cells L+C.p. % Cytotoxicity L+medium % Cytotoxicity
3 C. psittaci cells 23.3 ± 3.3 61b 34.4 ± 3.4 58
Control cells 59.8 ± 5.0 82.2 ± 6.8
C. psittaci sonic extract 60.4 ± 4.2 12 71 ± 5.1 19
Control sonic extract 68.8 ± 8.7 87.6 ± 8.6
Medium 86.5 ± 5.5 93.8 ± 4.2
M4)+C.p. M40+medium
14 C. psittaci cells 28.4 ± 4.4 43 90.6 ± 2.6 0
Control cells 49.4 ± 2.7 80.2 ± 7.6
C. psittaci sonic extract 63.9 ± 6.1 0.3 52.9 ± 1.2 13
Control sonic extract 64.1 ± 3.3 60.6 ± 7.5
Medium 85.3 ± 8.2 88.1 ± 6.3
a Spleen cells were harvested from C. psittaci-infected or control mice at 3 or 14 days postinfection and used
as effector cells. Effector cells at a ratio of 50:1 or an equivalent number of cells lysed by sonication were added
to target cells. On day 3, L cell monolayers were used as targets (L+C.p., L+medium); on day 14 macrophage
monolayers (M++C.p., M++medium) were used.
b The difference in uptake ofL cell + C.p. and L cell + medium target cells when incubated with C. psittaci or
control effectors was significant at P < 0.001. The difference in uptake of M4+C.p. targets when incubated with
C. psittaci or control effectors was significant at P < 0.01.
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TABLE 3. Comparison of effector cell cytotoxicity
for macrophage targets infected with infectious, UV-
treated, or heat-treated C. psittacia
Target cell [PH]uridine
infected with: Effector cell uptake Cytotoxicity(10' cpm ± SD) Cttxct
UV C. psittaci 43.7 ± 1.4 29b
Control 61.5 ± 4.5
Medium 75.5 ± 8.2
A C. psittaci 50 ± 4.8 29
Control 70.1 ± 7.2
Medium 81.2 ± 3.6
Infectious C. psittaci 48.3 ± 3.4 32
Control 70.6 ± 6.8
Medium 83.1 ± 6.7
Uninfected C. psittaci 67 ± 7.0
Control 63.4 ± 7.7
Medium 75 ± 7.4
a Mice were injected with 8 x 107 infectious C.
psittaci or PBS and boosted at 3 weeks. Spleens were
harvested 1 week later, and spleen cells were used as
effectors at a 50:1 ratio. Medium alone (uninfected) or
infectious, UV-, or heat-treated (A) C. psittaci were
centrifuged onto macrophage monolayers at 5:1, and
these were used as targets.
b The actual numbers represent the mean of three
separate experiments. The difference between C. psit-
taci and control effectors as measured by cytotoxicity
for infected targets was significant at P < 0.01.
with inactivated as well as infectious organisms
(Table 4). Since heat-treated organisms are tak-
en up at very low levels by L cells, it is possible
that the ability of these organisms to sensitize
target L cell monolayers with or without centrif-
ugation may be due to nonspecific stickiness of
heated organisms for the cell surface.
DISCUSSION
In this study, it was observed that spleen cells
from mice infected with the obligate intracellular
bacterium C. psittaci are capable of lysing either
C. psittaci-infected targets or both infected and
uninfected targets, depending on the time post-
infection. The observation that bacteria can in-
duce cytotoxic cells after in vivo injection is not
new. After injection of Corynebacterium par-
vum or Mycobacterium bovis bacillus Calmette-
Gudrin (BCG), the appearance of cells capable
of lysing tumor target cells has been reported
(15, 30). The activity of such cells against bacte-
ria, especially intracellular ones, has not been
tested however. The observed ability of effector
cells to lyse C. psittaci-infected targets in vitro
suggests that cytotoxic cells may play a role in
the control of some bacterial infections.
The first week after intraperitoneal injection
of C. psittaci into mice, the organisms could be
isolated from the spleen and liver at high titer.
During this early period of infection a distinct
pattern was observed. Initially (days 3 to 5)
uninfected and infected target cells were killed
with equal efficiency, but subsequently (day 7
on) infected targets were killed at much greater
efficiency. A similar pattern has been observed
in mice after viral infection with agents like
lymphocytic choriomeningitis virus (18, 29). It
has been demonstrated that after infection with
lymphocytic choriomeningitis virus, natural kill-
er cells are responsible for the early killing,
whereas cytotoxic T cells are responsible for the
later killing. Killing in this system peaked at 7 to
8 days and decreased rapidly thereafter. At 20
days postinfection, only marginal cytotoxicity
TABLE 4. Comparison of effector cell cytoxicity for L cell targets infected by centrifugation or shaking with
infectious, UV-treated, or heat-treated C. psittaciP
[3H]uridine uptake (103 cpm ± SD)
Target cell Effector cells
infected with: Centrifuge ShakeCytotoxicity
UV C. psittaci 51.2 ± 5.4 31b 40.2 ± 5.4 33
Control 74 ± 7.5 59.8 ± 6.4
Medium 87 ± 6.2 66.1 ± 6.3
A C. psittaci 48.2 ± 4.0 36 40.4 ± 1.6 25
Control 75.2 ± 6.8 53.6 ± 0.42
Medium 88.3 ± 3.4 68.3 ± 0.13
Infectious C. psittaci 45.2 ± 2.8 32 39.2 + 3.6 35
Control 66.8 ± 7.0 60.4 ± 4.7
Medium 75 ± 3.9 63.1 ± 6.3
Uninfected C. psittaci 75.6 ± 7.2 0.3 59 ± 5.2 1
Control 75.8 ± 7.8 54.8 ± 5.0
Medium 73 8.2 60.2 1.3
a Mice were injected with 8 x 10' infectious C. psittaci or PBS and boosted at 3 weeks. Spleens were
harvested 1 week later, and spleen cells were used as effectors at a 50:1 ratio. Medium alone (uninfected) or
infectious, UV-, or heat-treated (A&) C. psittaci were either centrifuged onto L cell monolayers or added to
monolayers followed by shaking at 15-min intervals for 4 h.
b The difference between C. psittaci and control effectors as measured by cytotoxicity for infected target was
significant at P < 0.01.
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was found. In contrast, after chlamydial infec-
tion the activity of effector cells for infected
targets continued, although at a reduced level,
beyond 21 days postinfection. It might be ex-
pected that the effector cell response to Chlamy-
dia may be more complex. As a bacterium, the
Chlamydia is far more complex than a virus.
Bacteria have been shown to possess a variety
of components which can modulate the immune
system of the host. Chlamydia, for example,
possess a gram-negative-like outer membrane. It
has become clear that cells capable of natural
cytotoxic activity are a heterogeneous group so
perhaps infection with Chlamydia results in the
activation of more than one type. Secondly, it is
known that the ability of cells to kill targets is
affected not only by factors before harvest but
also by in vitro factors (10). In vitro factors
would be expected to play a greater role on the
observed cytotoxicity during a 24-h incubation
period as opposed to the 4-h period commonly
used in studies with lymphocytic choriomeningi-
tis virus. Hibbs et al. (10) found, for example,
that activated macrophages from mice with
chronic BCG or toxoplasma infection could be
stimulated by low amounts of endotoxin or fetal
bovine serum in vitro to kill tumor cells. Infec-
tion with Chlamydia results in the presence of
activated macrophages so perhaps a similiar in
vitro activation of killing occurs.
In addition to the cytotoxicity observed in
spleen cells from infected mice, there does ap-
pear to be a low, varying amount of background
killing of infected targets by control spleen cells.
This can be observed by comparing the [3H]uri-
dine uptake of infected targets incubated with
control mice to the uptake of such targets when
incubated with medium. It is possible that this
may reflect natural killer cell activity. Although
originally thought to be nonspecific killers, stud-
ies have indicated that these effectors have some
specificity for targets. Piontek et al. (19) found,
for example, enhanced cytotoxicity of mouse
natural killer cells for vaccinia- and herpes virus-
infected targets. Piontek suggested that this aug-
mented killing of mouse natural killer lysis for
virus-infected cells might represent induction by
target cell-derived interferon in vitro. Similiar
augmented killing might occur after Chlamydia
infection of target cells.
Target cell sensitization occurs with inactivat-
ed Chlamydia, as well as with the infectious
organism. This indicates that host cell mem-
brane changes made upon entry, rather than
chlamydial antigen added during the replication
process, may be responsible for target cell sensi-
tization. The Chlamydia could leave antigen on
the surface during the entry process or the
change could be due to subtle membrane alter-
ations as a result of that process. It was ob-
served that heat-inactivated organisms could
sensitize L cells, despite their reduced ability to
induce uptake. We observed that heated organ-
isms tend to become stickier after treatment,
and it is possible that sensitization with these
organisms is due to nonspecific sticking to the
cell surface. Mycoplasma arthritidis have been
reported to sensitize cells to become cytotoxic
effectors (7). It was suggested that the mycoplas-
mas, which bind to the surface of cells, may
function as a glue, binding target cells to lym-
phocytes with preexisting cytotoxic potential.
The same sort of mechanism might occur with
heated chlamydial organisms on the surface of L
cells.
Cell-mediated cytotoxicity of the nature de-
scribed in this study may contribute to the
ability of the host to control chlamydial multipli-
cation in vivo. Studies characterizing the effec-
tor cells are currently underway. Such effectors
may play an important role in the initial control
of infection with a variety of viruses, bacteria,
and parasites, as well as tumors.
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